News

Recent news about Panacea Capital and select portfolio companies

January 30, 2026

US FDA Regulatory Meetings

Understanding the various types of regulatory meetings available with the US FDA is crucial for…

January 30, 2026

US FDA Regulatory Meetings

Understanding the various types of regulatory meetings available with the US FDA is crucial for…

January 29, 2026

Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company

This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…

January 29, 2026

Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company

This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…

January 29, 2026

Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company

Overview A US biotech company's Phase I oncology study had stalled under the management of…

January 29, 2026

Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company

Overview A US biotech company's Phase I oncology study had stalled under the management of…

January 28, 2026

Taiwan & Hong Kong: Strategic Hubs for Global Development

The APAC region continues to play a critical role in the global landscape of drug…

January 28, 2026

Taiwan & Hong Kong: Strategic Hubs for Global Development

The APAC region continues to play a critical role in the global landscape of drug…

January 28, 2026

Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty

Navigating the Next Few Years with Confidence   2025 has been marked by significant regulatory…

January 28, 2026

Why Australia & New Zealand Are Smart Alternatives for Your Clinical Trial During FDA Uncertainty

Navigating the Next Few Years with Confidence   2025 has been marked by significant regulatory…